Former top prospect Jesus Montero has been recalled by the Seattle Mariners, his first stint in the majors since a 50-game suspension after being connected to baseball’s Biogenesis performance-enhancing drug investigation.
Trades have arguably haunted the Seattle Mariners’ franchise more than any other team in Major League Baseball. Each week we’ll compile the three most-noteworthy trades that have happened between the Mariners and their current opponent. […]
Fernando Rodney gave up a run and two hits in his debut with the Seattle but Jesus Montero had two singles and an RBI to help the Mariners beat a Chicago White Sox split-squad 7-4 Thursday.
Jesus Montero was visibly nervous Wednesday as he apologized to his Seattle Mariners teammates and their fans.
Despite denying using performance-enhancing drugs in February, Mariners catcher and designated hitter Jesus Montero will not appeal a 50-game suspension being handed down by Major League Baseball for steroid use.
Baseball’s PED-Day is set to launch. The question now is whether this will stop the drug cheats once and for all.
While the Mariners are not leading the pack in the AL West — nor are they within striking range of a playoff spot — the 2013 season thus far is not the disaster it was on pace to be.
Major League Baseball, in a possible endgame to its ongoing investigation into the Biogenesis anti-aging clinic in South Florida that allegedly functioned as a PED “pipeline,” is reportedly angling to suspend, among others, Alex Rodriguez of the Yankees and Ryan Braun of the Brewers for 100 games each.
Jon Heyman of CBS Sports says Major League Baseball has started to interview players connected to the Biogenesis PED scandal. Heyman also reports investigators feel it’s likely some suspensions will be issued.
The Bleacher Report’s Adam Wells makes the argument that the Mariners’ infield prospect Nick Franklin could be making his way to the major league roster if his numbers continue to grow and Dustin Ackley’s continue to decline.